...
首页> 外文期刊>Clinical autonomic research: Official journal of the Clinical Autonomic Research Society >An alternative to treat palmar hyperhidrosis: use of oxybutynin.
【24h】

An alternative to treat palmar hyperhidrosis: use of oxybutynin.

机译:一种治疗手掌多汗症的替代方法:使用奥昔布宁。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the effectiveness and patient satisfaction with the use of oxybutynin at low doses for treating palmar hyperhidrosis in a large series of patients. METHODS: From January 2007 to June 2009, 180 consecutive patients with palmar hyperhidrosis were treated with oxybutynin. Data were collected from 139 patients (41 patients were lost to follow-up). During the first week, patients received 2.5 mg of oxybutynin once per day; from the 8th to the 42nd day, 2.5 mg twice per day; and from the 43rd day to the end of the 12th week, 5 mg, twice per day. All of the patients underwent three evaluations before and after the oxybutynin treatment (at 6 and 12 weeks), using a clinical questionnaire and a clinical protocol for quality of life (QOL). RESULTS: More than 80% of the patients experienced an improvement in palmar hyperhidrosis. Most of the patients showed improvements in their QOL (74.6%). The side effects were minor, with dry mouth being the most frequent (70.5%). CONCLUSION: The use of oxybutynin is an alternative as the first step in the treatment of palmar hyperhidrosis, given that it presents good results and improves QOL.
机译:目的:评估低剂量奥昔布宁治疗大量患者手多汗症的有效性和患者满意度。方法:自2007年1月至2009年6月,连续180例手掌多汗症患者接受奥昔布宁治疗。收集了139例患者的数据(41例失访)。在第一周,患者每天接受2.5毫克奥昔布宁治疗;从第8天到第42天,每天两次2.5 mg;从第43天到第12周末,每天两次,每次5毫克。使用奥昔布宁治疗前后(在第6和12周时),所有患者均接受了一项临床问卷和生活质量(QOL)临床方案的三项评估。结果:超过80%的患者手掌多汗症得到改善。大多数患者的生活质量得到改善(74.6%)。副作用很小,口干最常见(70.5%)。结论:奥昔布宁是治疗手足多汗症的第一步,因为它显示出良好的疗效并改善了生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号